TR201907776T4 - Kannabinoidleri içeren sakız bileşimleri. - Google Patents

Kannabinoidleri içeren sakız bileşimleri. Download PDF

Info

Publication number
TR201907776T4
TR201907776T4 TR2019/07776T TR201907776T TR201907776T4 TR 201907776 T4 TR201907776 T4 TR 201907776T4 TR 2019/07776 T TR2019/07776 T TR 2019/07776T TR 201907776 T TR201907776 T TR 201907776T TR 201907776 T4 TR201907776 T4 TR 201907776T4
Authority
TR
Turkey
Prior art keywords
chewing gum
compositions containing
gum compositions
containing cannabinoids
cannabinoids
Prior art date
Application number
TR2019/07776T
Other languages
English (en)
Inventor
Anne Van Damme Philippus
Evgeniyevich Anastassov George
Lekhram Changoer
Original Assignee
Stichting Sanammad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40793287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201907776(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Sanammad filed Critical Stichting Sanammad
Publication of TR201907776T4 publication Critical patent/TR201907776T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

Mevcut buluş, sakız bileşiminin toplam ağırlığına ve söz konusu sakızları içeren sakızlara ve kabarcıklı paketlere dayanarak, ağırlıkça %0.01 ila %15 oranında bir kannabinoid veya bunun bir türevini içeren bir sakız bileşimi ile ilgilidir.
TR2019/07776T 2008-03-26 2009-03-26 Kannabinoidleri içeren sakız bileşimleri. TR201907776T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3945108P 2008-03-26 2008-03-26

Publications (1)

Publication Number Publication Date
TR201907776T4 true TR201907776T4 (tr) 2019-06-21

Family

ID=40793287

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/07776T TR201907776T4 (tr) 2008-03-26 2009-03-26 Kannabinoidleri içeren sakız bileşimleri.

Country Status (15)

Country Link
US (2) US9023322B2 (tr)
EP (1) EP2280687B1 (tr)
BR (1) BRPI0910094B1 (tr)
CA (1) CA2719830C (tr)
DK (1) DK2280687T3 (tr)
ES (1) ES2727648T3 (tr)
HR (1) HRP20190944T1 (tr)
HU (1) HUE044439T2 (tr)
LT (1) LT2280687T (tr)
MX (1) MX2010010607A (tr)
PL (1) PL2280687T3 (tr)
PT (1) PT2280687T (tr)
SI (1) SI2280687T1 (tr)
TR (1) TR201907776T4 (tr)
WO (1) WO2009120080A1 (tr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2280687T3 (da) 2008-03-26 2019-05-27 Stichting Sanammad Tyggegummisammensætninger omfattende cannabinoider
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
WO2013147965A1 (en) * 2012-03-28 2013-10-03 Freeman Keith Gerald Medical compositions, methods of making and using those compositions, and kits including those compositions
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2527599A (en) 2014-06-27 2015-12-30 Gw Pharma Ltd Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
AU2015305215A1 (en) * 2014-08-22 2017-04-06 Medipath, Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
GB2531278A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
EP3253368A4 (en) * 2015-02-02 2018-08-22 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
US10945949B2 (en) * 2015-10-07 2021-03-16 Nordiccan A/S Medical chewing gum comprising cannabinoid
GB2548873B (en) 2016-03-31 2020-12-02 Gw Res Ltd Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
WO2017184584A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms
WO2017189375A1 (en) * 2016-04-27 2017-11-02 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and nicotine
US9901607B2 (en) 2016-04-28 2018-02-27 Mark J. Silen Smokeless cannabis composition and method of manufacture
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
WO2017202424A1 (en) * 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10765658B2 (en) * 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
WO2018002926A1 (en) 2016-06-28 2018-01-04 Seach Sarid Ltd. A dosage form for vaporization and smoking
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
GB2553139A (en) 2016-08-25 2018-02-28 Gw Res Ltd Use of cannabinoids in the treatment of multiple myeloma
US10278951B1 (en) 2016-09-29 2019-05-07 Jon Newland Method of treating opiate dependency using tetrahydrocannabinol extracts
EP3528804B1 (en) * 2016-10-20 2023-07-26 APIRX Pharmaceutical USA, LLC Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists
EP3488220A4 (en) * 2016-11-29 2020-03-04 Axim Biotechnologies, Inc. CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS AND NICOTINE
GB2557921A (en) 2016-12-16 2018-07-04 Gw Res Ltd Use of cannabinoids in the treatment of angelman syndrome
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
US20190224117A1 (en) * 2017-06-14 2019-07-25 Yury Leon Shmerlis Cannabis Extract Chewing Gum
CA3068088C (en) 2017-06-23 2024-01-23 Medcan Pharma A/S Cannabinoid pouch
US10272051B2 (en) 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
US11376227B2 (en) 2018-09-04 2022-07-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US20200069581A1 (en) * 2018-09-04 2020-03-05 Babak Ghalili Cannabinoid and anesthetic gum and lozenge compositions and methods
WO2020051055A2 (en) * 2018-09-04 2020-03-12 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
WO2020151792A1 (en) 2019-01-25 2020-07-30 Medcan Pharma A/S Cannabinoid chewing gum with improved release of cannabinoids
US11191720B2 (en) 2019-01-25 2021-12-07 Nordiccan A/S Chewing gum with improved delivery of cannabinoids
WO2020151789A1 (en) 2019-01-25 2020-07-30 Medcan Pharma A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11406593B2 (en) 2019-01-25 2022-08-09 Nordiccan A/S Cannabinoid chewing gum with high intensity sweeteners
WO2020151793A1 (en) 2019-01-25 2020-07-30 Medcan Pharma A/S Chewing gum with improved delivery of cannabinoids
US11013685B2 (en) 2019-01-25 2021-05-25 Nordiccan A/S Cannabinoid chewing gum with improved release of cannabinoids
EP3876742B1 (en) * 2019-01-25 2023-04-05 NordicCan A/S Cannabinoid chewing gum with high intensity sweeteners
US11166910B2 (en) 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
CN113423280A (zh) 2019-01-25 2021-09-21 诺狄更斯公司 具有糖醇的大麻素口香糖
US11154496B2 (en) 2019-01-25 2021-10-26 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US10799450B2 (en) 2019-03-01 2020-10-13 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
EP3930696A1 (en) 2019-03-01 2022-01-05 NordicCan A/S Tableted chewing gum with enhanced delivery of cannabinoids
AU2019432305B2 (en) 2019-03-01 2023-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US20200276118A1 (en) * 2019-03-01 2020-09-03 Medcan Pharma A/S Tableted cannabinoid chewing gum with improved release
WO2020177819A1 (en) 2019-03-01 2020-09-10 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
WO2020177821A1 (en) 2019-03-01 2020-09-10 Medcan Pharma A/S Tableted cannabinoid chewing gum with improved release
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
EP4030941A1 (en) 2019-09-16 2022-07-27 Vapor Cartridge Technology LLC Drug delivery system with stackable substrates
WO2021078999A1 (en) 2019-10-25 2021-04-29 Newmark Biotech, Llc Chewing gum or lozenge composition comprising cbd
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021177942A1 (en) * 2020-03-03 2021-09-10 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187320A (en) * 1978-05-01 1980-02-05 Warner-Lambert Company Process for preparing chewing gum base using solid elastomer
DK161428C (da) * 1985-05-10 1991-12-16 Fertin Lab As Fast, oralt cariesmodvirkende middel
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
CA2301282A1 (en) 1997-08-20 1999-02-25 Pradeepkumar P. Sanghvi Process for improving flow and compression of tableting compositions
AU2001261744A1 (en) 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
WO2002013781A1 (en) * 2000-08-14 2002-02-21 Fertin Pharma A/S Method for preparation of chewing gum with customer acceptable taste
GB2381194A (en) 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
GB2377633A (en) 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
US20020160043A1 (en) * 2001-02-27 2002-10-31 Dennis Coleman Compositions and method of manufacture for oral dissolvable dosage forms
FI20020333A0 (fi) * 2002-02-20 2002-02-20 Tomi Jaervinen Metyloidun syklodekstriinin uudet kompleksit
US20060257463A1 (en) 2002-05-31 2006-11-16 University Of Mississippi Transmucosal delivery of cannabinoids
US7004174B2 (en) 2002-05-31 2006-02-28 Neothermia Corporation Electrosurgery with infiltration anesthesia
WO2004004479A1 (en) * 2002-07-02 2004-01-15 Gumlink A/S Compressed chewing gum
US6986907B2 (en) 2003-07-28 2006-01-17 Wm. Wrigley Jr. Company Chewing gum base and chewing gum compositions
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
GB2414933B (en) 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
GB0416861D0 (en) * 2004-07-29 2004-09-01 Quadrant Drug Delivery Ltd Composition
WO2006026298A2 (en) * 2004-08-25 2006-03-09 Cadbury Adams Usa Llc Liquid-filled chewing gum composition
GB2432312A (en) 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
US20100061940A1 (en) 2006-03-16 2010-03-11 Niconovum Ab Chewing Gum Compositions Providing Rapid Release of Nicotine
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US9308175B2 (en) 2006-09-15 2016-04-12 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
DK2280687T3 (da) 2008-03-26 2019-05-27 Stichting Sanammad Tyggegummisammensætninger omfattende cannabinoider

Also Published As

Publication number Publication date
BRPI0910094B1 (pt) 2021-08-10
DK2280687T3 (da) 2019-05-27
US9433601B2 (en) 2016-09-06
EP2280687A1 (en) 2011-02-09
WO2009120080A1 (en) 2009-10-01
CA2719830F (en) 2009-10-01
MX2010010607A (es) 2011-03-29
PL2280687T3 (pl) 2019-10-31
BRPI0910094A2 (pt) 2015-12-15
HRP20190944T1 (hr) 2019-09-20
US9023322B2 (en) 2015-05-05
CA2719830A1 (en) 2009-10-01
SI2280687T1 (sl) 2019-09-30
HUE044439T2 (hu) 2019-10-28
LT2280687T (lt) 2019-08-26
US20150209322A1 (en) 2015-07-30
US20110097283A1 (en) 2011-04-28
CA2719830C (en) 2017-08-08
PT2280687T (pt) 2019-06-04
EP2280687B1 (en) 2019-02-27
ES2727648T3 (es) 2019-10-17

Similar Documents

Publication Publication Date Title
TR201907776T4 (tr) Kannabinoidleri içeren sakız bileşimleri.
CY1113267T1 (el) Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1
CR20150097A (es) Composición inmunogénica
CR11454A (es) Derivados de isoxazolo-piridina
TW200621313A (en) Pharmaceutical compositions
EA201170884A1 (ru) Производные пиперидина, пригодные в качестве антагонистов орексина
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
BRPI0911847B8 (pt) composições de pastilha de nicotina
BRPI0519414A2 (pt) composiÇço oral, composiÇço em pasta ou gel, e, mÉtodos para inibir crescimento bacteriano na cavidade oral, e para manter saéde sistÊmica
DE602008004265D1 (de) Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
EA201070519A1 (ru) Соединения тропана
EA201071056A1 (ru) ПРИМЕНЕНИЕ (1→3)-β-D-ГЛЮКАНА В КАЧЕСТВЕ СТАБИЛИЗАТОРА ЭМУЛЬСИИ
MA30042B1 (fr) Composes calcilytiques
HK1154777A1 (en) Lipoprotein lipase-activating compositions comprising benzene derivatives
SV2010003723A (es) Derivados de piperidina 3,4-sustituida como inhibidores de renina
DK1971216T3 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
CY1116266T1 (el) Σταθερα αλατα της s-αδενοσυλμεθειονινης και μεθοδος παρασκευης τους
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
BR112012018202A2 (pt) Bases de goma que têm adesão reduzida a superfícies ambientais.
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
ATE522515T1 (de) Modulatoren der dopamin-neurotransmission
WO2009004164A3 (fr) Derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK2004149T3 (da) Farmaceutiske sammensætninger indeholdende leflunomid